drugset / Trial / NCT00861341

Effects of Pioglitazone on Platelet Function

NCT00861341

Phase 2 Completed 40 enrolled University of Rochester
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine how pioglitazone and aspirin affect platelets in the blood of diabetic and non-diabetic subjects. Platelets are small cells in the blood that help with blood clotting. Pioglitazone is a drug that is used to lower blood sugar and fats by helping the body to use insulin correctly. Pioglitazone is presently used to treat diabetes but has not been approved for non-diabetics. This study will determine whether pioglitazone reduces the activity of platelets in people who are or are not also taking aspirin.

Timeline

Start
2008-12
Primary completion
2010-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg Oral
Subject Pioglitazone Small molecule 30 mg Oral